Vicebio Avian Influenza (H5) vaccine

Vicebio's Avian Influenza (H5) vaccine is a preclinical-stage vaccine candidate designed to protect against the H5N1 strain of avian influenza. The vaccine utilizes Vicebio's proprietary Molecular Clamp technology, which is engineered to stabilize viral fusion proteins, such as the H5 hemagglutinin, in their native pre-fusion conformation. By locking the protein into this highly immunogenic state, the vaccine aims to present the most relevant epitopes to the immune system, thereby inducing a more potent and broad neutralizing antibody response compared to traditional vaccine platforms. This candidate is part of a broader portfolio of respiratory vaccines developed by Vicebio to address pandemic threats and seasonal viral infections.

Other names

H5 hemagglutinin vaccineH-5 hemagglutinin vaccineH 5 hemagglutinin vaccineMolecular Clamp H5 vaccine